Ortho Optix™ Reader
ID-MTS™ Gel Test
Do better with lessA time ofchallenges
The world is changing. Increased demands anddecreased resources are having a significant impact
on labs everywhere. QuidelOrtho’s automated andsemi-automated systems are designed to help bloodbanks meet the challenges of today — and tomorrow— with proven technologies and a scalable platform
designed to elevate your standard of patient care.
Now more than ever, you need a proven partner
For over 80 years, blood bankers have trusted
QuidelOrtho to help to ensure the safety of theirpatients’ transfusions and increase the efficiency of
their labs. With over 5,500 placements across theglobe, a patient is safely transfused every second due
to QuidelOrtho’s portfolio of pre-transfusion testing.
The freedom to focus
Award-winning services and Informatics is theevolution of how service, expertise, technology
and data-driven solutions come together to createa more effective, efficient lab — so you can focus
on improving patient care.

Today’s transfusion medicine professionals
face unprecedented challenges
Demographic shifts
Increasing testing volumeand complexity
Budgetary pressures
Evolving regulatory requirements
Skilled resource shortages

A portfolioof solutions
Our comprehensive portfolio of automated and semi-automatedsolutions is designed to help you control your operations, optimize
your resources and trust your results — regardless of the size orvolume of your testing needs
Deliver a high quality and safe1 result with a lower
volume solution

99.9%• Scalable solutions designed with the same imaging andinterpretation system as our Ortho Vision® Platform to ensure
a consistent and high quality result

concordance2• Easy-to-use and easy-to-train with online video tutorials

Standardize your processes to consistently
deliver excellence• Consistent performance and compliance help standardize

processes across shifts with enhanced data traceability andreporting capabilities, QC management and the ability to track
tests and reagents• Our team of dedicated lab specialists can support technicalquestions and help select the right tests for your lab

Drive efficiency and streamline your workflow

1234• Centralize your results and streamline your lab’s workflow tohelp eliminate the need for manual documentation and reduce
the risk of transcription errors• E-Connectivity Technology enables virtual troubleshooting®

and quick support from our award-winning service andinformatics teamAt the heart of this solution is Ortho Optix™ Reader — an advanced card reader designed to automate reaction
grading and elevate your lab’s performance to the highest level.
1. Data on file. CAT # 59431: EXPERT READER GAGE R&R Study.
2. For direct and indirect antiglobulin testing, as determined by external validation testing using QuidelOrtho technology. The acceptance criteria for concordance for direct andindirect antiglobulin was 98.0% with a lower bound 95% CI of 99.7% (Data on file. D50425 Reader_Report_02062020: BioVue EET).
quidelortho.com | 3

Integrated tools.
Improved workflow.
Better together.

Partners in performance
The Ortho Optix™ Reader works with the Ortho® Workstation — the only compact 2-in-1
blood testing system with reliable Ortho ID-Micro Typing System™ (ID-MTS™) Gel Card
Column Agglutination Technology (CAT), to provide an accurate, cost-effective screening
solution that contributes to your ability to deliver consistent results with confidence.

4 | quidelortho.com

How Ortho Optix™ Reader
benefits your lab:
• Ensures accurate results: Proven to deliver 99.9%
concordance1 for a high-quality and consistent
result by utilizing the same interpretation systemand camera image sensor of our award-winning
automated Ortho Vision/Vision Swift platform• Eliminates the guesswork: High-resolution camera

captures high-resolution images of each side of thereaction column to determine the result, eliminating
the subjectivity and discrepancies associated withhuman reading of results. Let the high-resolution
camera of Ortho Optix Reader focus on the result,
so your staff can focus on other critical tasks• Minimizes manual errors: Delivers results directly

to your computer or from a bidirectional interface
to your laboratory information system (LIS),2 greatly
reducing or eliminating the need for manual
documentation and the risk of transcription errors• Improves workflow efficiency & safety: Cutting-edge software designed with customizable
workflow settings enables enhanced traceability
and reporting capabilities to keep labs compliant
with accreditations and regulations• Maximize your testing ability with cutting-edge
technology: Uses best-in-class ID-MTS Gel Test
technology, which offers a comprehensive
testing menu

Advancing transfusion
medicine, improving
patient care
Learn with industry experts and thought
leaders through our QuidelOrtho Science
Bytes monthly podcasts, webinars, videos
and additional resources — some of which
provide the opportunity to earn Professional
Acknowledgment for Continuing Education.
You’ll gain invaluable knowledge to help yourlab maximize performance and help achieve
better patient outcomes.
Learn more at quidelortho.com

For direct and indirect antiglobulin testing, as determined by External Validation Testing using ID-MTS Technology. The acceptance criteria for concordance for direct andindirect antiglobulin was ≥98% with a lower bound 95% CI of 99.87%.
1

Bidirectional interface to an LIS is optional.

2

quidelortho.com | 5

Specifications
Ortho Optix Reader
Dimensions
Height: 240 mm (9.45 in)
Width: 215 mm (8.46 in)Depth: 435 mm (17.13 in)
Weight5.4 kg (11.9 lbs)
Power requirements
100–240 V~, 50/60 Hz, single-phase(input auto-senses voltage/current, nomanual selection required)Power consumption
150 VA

Computer specifications
Browser requirementGoogle Chrome
Operating system
Microsoft® Windows® 10 Enterprise or
Microsoft Windows 10 Professional
NOTE: The Ortho Optix Reader does notsupport Microsoft Windows 10 Home or
Microsoft Windows 10 Education
Processor
Intel i5 CPU or higher
MemoryMinimum of 8GB RAM
USB ports
2 minimum: 1 each for Ortho Optix
Reader and bar code scanner.
Additional ports may be required for
keyboard, mouse, and USB printerMonitor
Minimum resolution of 1,920 × 1,080
Network connection
Needed for LIS and E-Connectivity
Malware protection
Customer supplied. Needs toinclude anti-malware/anti-virus

6 | quidelortho.com

Barcode reader
specifications
Reads, with auto-discrimination
capability, the standard barcode
symbology listed below.
The following barcode symbology isrequired for reading cards as well as
QuidelOrtho-branded reagents andQC fluids.

• Interleaved 2 of 5
• Code 128
Configuration of the barcode reader
symbology for sample containers isdependent on the sample containers
used by the lab. Commonly used
symbology for sample containers is:• Code 39• Codabar• Interleaved 2 of 5
• Code 128 (includes A, B & C formats
and ISBT 128 content)

Printer specifications
Characteristic
Printers that are supported byMicrosoft Windows 10. Either
networked or USB connected.
Description
Serves as an output device for printed
system reports, including:• Order results report• Quality control report• Quality control history report• Laboratory report• Assay statistics report• Blood group report• Consumable lot report

Ortho Workstation
Dimensions
Height: 220 mm (8.66 in)Width: 575 mm (22.64 in)
Depth: 325 mm (12.80 in)
Weight10.89 kg (24 lbs)
Power requirements
100–240 V~, 50/60 Hz, single-phase(input auto-senses voltage/current,
no manual selection required)Power consumption
150 VAFuses
2 required, T4AH250V–4 amp, 250 V,ceramic, time delay, 5 × 20 mm
Cycle speed
Phase 1: 793 rpm ± 10 rpm
Phase 2: 1,509 rpm ± 10 rpm
Speed indicator
4 digits
Timing indicator
4 digits
Cycle timing
10 minutes ± 10 seconds(including ramp-up time)
Centrifuge card/cassette capacity
10 cards/cassettes
Incubation temperature
37°C ± 2°C
Incubator card/cassette capacity
20 cards/cassettes(2 sections of 10)
Noise level generated
Maximum 50 dBA at 1 meter(during normal operation)

Ordering information
QuidelOrtho ID-MTS™ Configuration Table
Formal Name

123456

A/B/D Reverse Grouping

Anti-A

Anti-B

Anti-D

Control

Buffered

Buffered

A/B/D Monoclonal Grouping

Anti-A

Anti-B

Anti-D

Anti-A

Anti-B

Anti-DA/B Monoclonal Grouping

Anti-A

Anti-B

Anti-A

Anti-B

Anti-A

Anti-B

Anti-cAnti-eControl

Anti-A,B

Anti-A,B

Anti-A

Anti-A

Anti-B

Anti-B

Anti-D

Anti-D

Monoclonal Control

Control

Monoclonal Rh Phenotype

Anti-D

Anti-C

Anti-E

Anti-C

Anti-C

Anti-E

Anti-E

Anti-cAnti-cAHG PolyspecificAnti-IgG, C3d, Polyspecific

AHG Anti-IgG

Anti-IgG

Buffered

Buffered

Product availability is subject to fulfillment of regulatory requirements in each market.

Nearly 40 percent of the global
transfusion medicine market relieson QuidelOrtho solutions.
For more information, contact yourQuidelOrtho Representative
US-CustomerService@quidelortho.com | quidelortho.com*Market share is based on 2021 market size in reported revenue,
2020-2021 growth in constant exchange rate.

New QuidelOrtho branding may not be available in all markets, subject to country
specific regulatory approval. Please confirm with your local commercial team.

9975 Summers Ridge RoadSan Diego, CA 92121 USA
At QuidelOrtho, we transform diagnostic data into answers, understanding andaction, illuminating the path forward for all. For more than 80 years, we’ve pursued
the unknown with a passion and purpose to improve health. And we’ll continue totransform the power of diagnostics into a healthier future for all.

quidelortho.com
PR-13732© 2023 QuidelOrtho Corporation